Ebola response workers at a treatment center in Bunia, DR Congo, have gone on strike as the death toll rises. The stoppage threatens day-to-day operations such as patient care, isolation, and safe burials.
10:33 PMAl Jazeera26 stories from 12 sources
Public health defenses fray while legal exposure tightens
Day’s Recap
Ebola containment in DR Congo and global HIV programs showed acute strain from worker strikes and funding cuts, while Johnson & Johnson and Weill Cornell moved to settle massive legal claims that tested institutional accountability.
Regulatory skepticism toward a rare disease therapy and a looming radiopharma merger added further uncertainty to patient access and market concentration. Together, the day underscored that health systems and the entities that serve them are simultaneously confronting operational breakdowns, financial liabilities, and consolidation pressures.
Supporting Articles
Johnson & Johnson proposed a settlement of up to $5.5 billion to resolve claims that its talc-based baby powder caused cancer. The offer is intended to end years of litigation and bring closure across a large docket of cases.
9:53 PMBBCUNAIDS warns the HIV response is at risk after international financing fell 18% last year. The report frames the drop as a major shock that could reverse recent progress in prevention and treatment.
4:45 PMStat NewsWeill Cornell Medical Center settled a federal probe into allegations it failed to stop sexual abuse by former urologist Darius Paduch. The inquiry grew out of Paduch’s case and focused on whether the institution ignored warning signs and let abuse continue.
1:15 PMGothamistCurium is in advanced talks to buy Lantheus Holdings in a deal valued at about $7 billion. The transaction could be announced within days, according to people familiar with the talks.
5:22 PMBloomberg MarketsAhead of an upcoming hearing, FDA reviewers raised doubts about the evidence that Capricor’s Duchenne muscular dystrophy treatment provides meaningful benefit. The review adds uncertainty to the drug’s regulatory path in a high-need rare disease.
9:08 AMStat NewsOfficials say tests found living Legionella bacteria in cooling towers at 56 buildings on the Upper East Side. The findings come amid concern about a legionnaires’ disease outbreak and focus attention on building maintenance and compliance.
2:38 PMGothamist10:33 PMAl Jazeera
Ebola response workers strike in DR Congo as death toll spikes
Summary
Ebola response workers at a treatment center in Bunia, DR Congo, have gone on strike as the death toll rises. The stoppage threatens day-to-day operations such as patient care, isolation, and safe burials.
A labor disruption is now directly weakening the outbreak containment apparatus. Patients, surrounding communities, and
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
When response staffing fails, Ebola outbreaks can expand quickly, raising regional risk and increasing the eventual cost and complexity of control.
9:53 PMBBC
Johnson & Johnson offers up to $5.5bn to settle baby powder lawsuits
Summary
Johnson & Johnson proposed a settlement of up to $5.5 billion to resolve claims that its talc-based baby powder caused cancer. The offer is intended to end years of litigation and bring closure across a large docket of cases.
J&J is moving to cap legal exposure with a single, high-dollar deal rather than fight
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A global settlement can reshape corporate risk calculus for consumer health products and define compensation norms for alleged harm.
2 stories · 2 sources
4:45 PMStat News
STAT+: HIV resurgence is feared as global funding to combat the disease falls 18%
Summary
UNAIDS warns the HIV response is at risk after international financing fell 18% last year. The report frames the drop as a major shock that could reverse recent progress in prevention and treatment.
A sharp funding contraction is forcing programs to scale back testing, prevention, and treatment continuity.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
HIV control depends on sustained coverage, and funding breaks can rapidly translate into preventable infections and deaths.
1:15 PMGothamist
Weill Cornell settles federal probe of claims it allowed sexual abuse to go unchecked
Summary
Weill Cornell Medical Center settled a federal probe into allegations it failed to stop sexual abuse by former urologist Darius Paduch. The inquiry grew out of Paduch’s case and focused on whether the institution ignored warning signs and let abuse continue.
A federal investigation ended in a settlement rather than a contested finding, shifting the risk
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The outcome sets practical accountability pressure on major medical institutions to detect and stop clinician abuse earlier, not just punish it later.
5:22 PMBloomberg Markets
Curium Is Said to Near About $7 Billion Acquisition of Lantheus
Summary
Curium is in advanced talks to buy Lantheus Holdings in a deal valued at about $7 billion. The transaction could be announced within days, according to people familiar with the talks.
Consolidation in radiopharma is accelerating as buyers chase scarce production capacity and late-stage imaging and
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Radiopharma scale can determine whether health systems get timely imaging and therapy or face higher costs and supply constraints.
9:08 AMStat News
STAT+: Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drug
Summary
Ahead of an upcoming hearing, FDA reviewers raised doubts about the evidence that Capricor’s Duchenne muscular dystrophy treatment provides meaningful benefit. The review adds uncertainty to the drug’s regulatory path in a high-need rare disease.
The shift is FDA signaling skepticism on efficacy before a public forum, which increases the
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
FDA pushback can reset expectations for what evidence is enough in Duchenne, affecting multiple pipelines and patient access timelines.
2:38 PMGothamist
Officials identify UES cooling towers that had living Legionella bacteria before outbreak
Summary
Officials say tests found living Legionella bacteria in cooling towers at 56 buildings on the Upper East Side. The findings come amid concern about a legionnaires’ disease outbreak and focus attention on building maintenance and compliance.
Public health officials have now tied outbreak risk to a broad set of identifiable building
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Legionella in dozens of towers turns routine building operations into a citywide health and regulatory problem.
Other Developments
A curated list of other prominent stories from this day.
Telehealth services in rural Zimbabwe are enabling remote consultations that reduce long, costly travel to clinics. The model aims to make basic care more accessible and affordable for underserved communities.
10:08 PMAl JazeeraSen. Rand Paul released a batch of Dr. Anthony Fauci's COVID-era diary entries ahead of Fauci's scheduled Senate testimony on coronavirus origins. The notes document Fauci's daily schedule and interactions during key phases of the pandemic response.
8:05 PMNPR PoliticsA new study reports cognitive improvements among people who limited daily eating to an 8 or 9 hour window. The findings suggest meal timing may affect brain function, not just weight or metabolic markers.
5:37 PMMarketWatchExperts say consolidation in the produce supply chain is amplifying cyclospora outbreaks by concentrating sourcing, processing, and distribution. That structure can push contaminated product across wider geographies before detection and recall.
3:48 PMCNBCNew York City has faced repeated Legionnaires’ disease outbreaks in recent years, underscoring persistent environmental sources of the bacteria. Some experts argue the city should focus more on risks inside building plumbing systems, including shower heads, not only large external equipment.
2:30 PMNYT New YorkThe piece argues that industry messaging is steering attention away from the drivers of rising prescription drug spending. It also flags related developments including job lock dynamics, prescription cost growth, and an update tied to the No Surprises Act.
2:13 PMStat NewsCarly Simon revealed she has Parkinson’s disease and said she intends to keep singing. She also disclosed she has received treatment for skin cancer.
10:04 AMBBCAn FDA advisory panel recommended allowing compounding pharmacies to make two additional peptides. The vote aligns with efforts to broaden access to certain peptide products through compounding.
9:19 AMStat NewsA small preliminary study found unsweetened sparkling water causes only a brief dip in salivary pH, unlike soda which drives a deeper, longer acidity drop. The measured acidity with sparkling water stayed above levels typically linked to enamel damage.
8:52 AMScienceDailyOak Hill Bio launched with backing from RA Capital and other investors to develop a new medicine for Angelman syndrome. The startup will compete directly with established rare-disease players Ultragenyx and Ionis in a high-need neurological indication.
8:00 AMStat NewsApnimed, a late-stage developer of a drug for sleep apnea, is pursuing a US IPO to raise up to $160 million. The company is backed by Shionogi and is positioning its program as a pharmacologic alternative in a market dominated by devices.
7:33 AMBloomberg MarketsPediatric clinicians report a sharp rise in serious injuries linked to e-bikes and e-scooters, increasingly showing up in emergency departments. The authors argue the injury severity and volume now warrant a public health response rather than treating incidents as isolated accidents.
4:30 AMStat NewsA nurse-midwife argues clinicians can counter medical misinformation by building trust over time and using patient-centered communication rather than trying to win arguments. The piece emphasizes seed-planting, relationship continuity, and practical counseling as tools to move decisions toward evidence-based care.
4:30 AMStat NewsA controlled mouse study showed inherited genetic background can shape how cancers start and evolve after the same DNA damage exposure. The findings point toward better prediction of cancer risk and more tailored screening and treatment strategies.
4:29 AMScienceDailyArgenx agreed to acquire Forte Biosciences for $2.2 billion to add an autoimmune drug program to its pipeline. The deal signals Argenx is using its balance sheet to broaden beyond its current lead franchise and deepen its presence across immune-mediated diseases.
3:26 AMStat News10:08 PMAl Jazeera
How telehealth is helping close the healthcare gap in rural Zimbabwe
Summary
Telehealth services in rural Zimbabwe are enabling remote consultations that reduce long, costly travel to clinics. The model aims to make basic care more accessible and affordable for underserved communities.
Virtual care is shifting access from geography to connectivity and system capacity. Rural patients gain
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Telehealth can narrow rural health inequities, but only if infrastructure and follow-through turn consultations into effective care.
8:05 PMNPR Politics
Rand Paul releases Anthony Fauci's pandemic-era diary notes. Here's what they tell us
Summary
Sen. Rand Paul released a batch of Dr. Anthony Fauci's COVID-era diary entries ahead of Fauci's scheduled Senate testimony on coronavirus origins. The notes document Fauci's daily schedule and interactions during key phases of the pandemic response.
Paul is widening the oversight fight by shifting from policy disputes to personal records timed
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The release adds fuel to a long-running campaign to delegitimize pandemic-era public health leadership and reshape voter trust in government expertise.
5:37 PMMarketWatch
Stop snacking. Restricting eating for only 8 or 9 hours a day may keep your mind sharp.
Summary
A new study reports cognitive improvements among people who limited daily eating to an 8 or 9 hour window. The findings suggest meal timing may affect brain function, not just weight or metabolic markers.
The shift is from calorie-focused advice to time-based eating as a potential cognitive intervention. If
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
If meal timing reliably improves cognition, it offers a scalable behavioral lever for brain health with minimal medical infrastructure.
2 stories · 2 sources
3:48 PMCNBC
Consolidated food supply may be worsening cyclospora outbreaks, experts say
Summary
Experts say consolidation in the produce supply chain is amplifying cyclospora outbreaks by concentrating sourcing, processing, and distribution. That structure can push contaminated product across wider geographies before detection and recall.
Outbreak risk is shifting from isolated farm or field failures to systemwide propagation through centralized
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A more consolidated food system can turn a single contamination event into a multistate public health problem.
2:30 PMNYT New York
Legionnaires’ Disease Has Made a Home in New York City. Here’s How.
Summary
New York City has faced repeated Legionnaires’ disease outbreaks in recent years, underscoring persistent environmental sources of the bacteria. Some experts argue the city should focus more on risks inside building plumbing systems, including shower heads, not only large external equipment.
The risk narrative is shifting from cooling towers to everyday plumbing, which would widen the
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A plumbing-focused approach could reduce outbreaks but would expand compliance burdens across much of the city’s building stock.
2:13 PMStat News
STAT+: Pharma’s drug spending deflection
Summary
The piece argues that industry messaging is steering attention away from the drivers of rising prescription drug spending. It also flags related developments including job lock dynamics, prescription cost growth, and an update tied to the No Surprises Act.
The policy fight is shifting toward who gets blamed for drug spending growth and which
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Who wins the blame game shapes the next round of drug pricing policy and determines whether costs fall for patients or just move around the system.
10:04 AMBBC
Carly Simon reveals Parkinson's diagnosis
Summary
Carly Simon revealed she has Parkinson’s disease and said she intends to keep singing. She also disclosed she has received treatment for skin cancer.
Simon has publicly tied her health to her career timeline while emphasizing ongoing creative capacity.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Her openness resets expectations for longevity and accommodation for aging artists navigating chronic illness.
3 stories · 3 sources
9:19 AMStat News
STAT+: Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more
Summary
An FDA advisory panel recommended allowing compounding pharmacies to make two additional peptides. The vote aligns with efforts to broaden access to certain peptide products through compounding.
The decisive shift is regulatory momentum toward expanding what compounders can produce, widening the supply
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Expanding compounded peptides can increase access quickly but raises high-stakes questions about safety, oversight, and market disruption.
8:52 AMScienceDaily
Scientists reveal what sparkling water really does to your teeth
Summary
A small preliminary study found unsweetened sparkling water causes only a brief dip in salivary pH, unlike soda which drives a deeper, longer acidity drop. The measured acidity with sparkling water stayed above levels typically linked to enamel damage.
The key shift is that sparkling water looks meaningfully less erosive than soda under mouth-acidity
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
It supports sparkling water as a lower-risk swap for soda while keeping focus on frequency and formulation as the real dental risk drivers.
8:00 AMStat News
STAT+: RA Capital backs upstart rival to Ultragenyx and Ionis in rare brain disease
Summary
Oak Hill Bio launched with backing from RA Capital and other investors to develop a new medicine for Angelman syndrome. The startup will compete directly with established rare-disease players Ultragenyx and Ionis in a high-need neurological indication.
RA Capital is funding a new entrant to challenge incumbents in Angelman syndrome. That increases
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A well-capitalized startup entering Angelman can reset timelines and valuations across the program landscape in rare neuro.
7:33 AMBloomberg Markets
Shionogi-Backed Apnimed Seeks to Raise $160 Million in US IPO
Summary
Apnimed, a late-stage developer of a drug for sleep apnea, is pursuing a US IPO to raise up to $160 million. The company is backed by Shionogi and is positioning its program as a pharmacologic alternative in a market dominated by devices.
A late-stage sleep apnea drug is moving from private funding to public markets. If the
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Public funding for a late-stage sleep apnea drug signals renewed capital access for near-commercial therapeutics in a large, device-led category.
4:30 AMStat News
Opinion: E-bikes, e-scooters are a burgeoning pediatric public health emergency
Summary
Pediatric clinicians report a sharp rise in serious injuries linked to e-bikes and e-scooters, increasingly showing up in emergency departments. The authors argue the injury severity and volume now warrant a public health response rather than treating incidents as isolated accidents.
The shift is from individual responsibility to systems-level prevention: speed, device design, and weak local
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Without guardrails, pediatric trauma will scale with micromobility adoption and strain emergency care capacity.
4:30 AMStat News
Opinion: How midwives like me can help fight medical misinformation
Summary
A nurse-midwife argues clinicians can counter medical misinformation by building trust over time and using patient-centered communication rather than trying to win arguments. The piece emphasizes seed-planting, relationship continuity, and practical counseling as tools to move decisions toward evidence-based care.
The shift is tactical: prioritize durable trust and behavior change over immediate persuasion. Midwives and
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Maternal and infant outcomes hinge on whether trusted clinicians can keep patients engaged with evidence-based care.
4:29 AMScienceDaily
Why the same DNA damage causes cancer in some people but not others
Summary
A controlled mouse study showed inherited genetic background can shape how cancers start and evolve after the same DNA damage exposure. The findings point toward better prediction of cancer risk and more tailored screening and treatment strategies.
The shift is direct evidence that host genetics can steer tumor evolution even when the
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
It moves cancer risk from a one-exposure-fits-all frame toward genetically stratified prevention and surveillance.
3:26 AMStat News
STAT+: Argenx to buy Forte Biosciences for $2.2B
Summary
Argenx agreed to acquire Forte Biosciences for $2.2 billion to add an autoimmune drug program to its pipeline. The deal signals Argenx is using its balance sheet to broaden beyond its current lead franchise and deepen its presence across immune-mediated diseases.
The decisive shift is Argenx moving from organic pipeline build to buying late-stage optionality in
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Big-ticket immunology M&A reshapes which mechanisms get funded and how quickly new autoimmune treatments reach trials and clinics.
Make it yours
Build Your First Pass.
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!